RYM RYM
Company Profile ↓Company Overview
RYM (RYM) is a publicly traded company listed on with a market capitalization of $53.71M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $17.28M (+95916.7% YoY); net profit $-33.26M.
- 5-Year Trend Long-term compounding — revenue CAGR 9.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 9.35% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +1.01% |
| 6 Months: | +54.74% |
| 3 Months: | -9.52% |
| 1 Month: | +4.26% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)61.02 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 48.2% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.01M | 3.91M | 2.81M | 7.01M | 11.82M | 15.75M | 26.02M | 19.33M | 7.02M | 5.80M | 5.07M | 3.14M | 2.60M | 2.99M | 1.93M | - | 538.00K | 2.04M | 4.04M | 10.66M | 13.29M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 448.00K | 1.36M | 2.67M | 2.62M | 2.89M |
| Gross Profit | 41.00K | 1.02M | -199.00K | -540.00K | 527.00K | -380.00K | 4.17M | 1.61M | -4.12M | 988.00K | 600.00K | 974.00K | 729.00K | 1.13M | 225.00K | - | 90.00K | 682.00K | 1.38M | 8.04M | 10.40M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.79M | 7.48M | 10.26M | 12.52M | 14.43M |
| Operating Income | -3.45M | -2.44M | -2.58M | -6.50M | -5.43M | -9.80M | -9.76M | -91.53M | -31.55M | -7.58M | -5.34M | -4.58M | 353.00K | -853.00K | -1.22M | - | -3.70M | -6.80M | -8.89M | -4.48M | -4.03M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.37M | -6.43M | -7.79M | -8.22M | -591.00K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 90.00K | - | 291.00K | 1.13M | 1.78M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.27M | -7.21M | -10.63M | -13.63M | -5.67M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | -25.59M |
| Net Income | -3.41M | -2.44M | -2.71M | -3.84M | -5.64M | -9.76M | 1.78M | -74.60M | -57.41M | -10.33M | -6.80M | -2.09M | 4.24M | -2.97M | -18.65M | - | -1.63M | -7.36M | -10.66M | -13.61M | 19.92M |
| Diluted EPS | - | - | -0.67 | -0.33 | -0.28 | -4.68 | 13.79 | -561.31 | -429.98 | -9.63 | -4.39 | -19.02 | 3.78 | -3.16 | -17.28 | - | -0.83 | -3.74 | -5.33 | -6.62 | 1.33 |
| R&D Expense | 1.20M | 743.00K | 449.00K | 882.00K | 774.00K | 827.00K | 2.08M | 2.44M | 1.75M | 735.00K | 643.00K | 486.00K | 275.00K | 185.00K | 168.00K | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | 12.09M | - | 58.26M | 15.14M | 18.00K | 17.28M |
| Cost of Revenue | - | - | 90.05M | 11.12M | 89.00K | 7.09M |
| Gross Profit | 570.00K | - | -31.80M | 4.02M | -71.00K | 10.19M |
| Operating Expenses | - | - | 90.87M | 18.35M | 7.18M | 34.05M |
| Operating Income | -12.62M | - | -122.67M | -14.33M | -7.25M | -23.86M |
| EBITDA | - | - | -119.62M | -9.39M | -21.55M | -25.38M |
| Interest Expense | - | - | - | 2.15M | 256.00K | 3.20M |
| Pretax Income | - | - | -188.28M | -13.43M | -23.23M | -34.74M |
| Tax Provision | - | - | 23.00K | 2.00K | -2.00K | 0 |
| Net Income | -21.62M | - | -188.17M | -18.65M | -41.75M | -33.26M |
| Diluted EPS | -5.32 | - | -13,532.85 | -187.64 | -40.92 | -16.68 |
| R&D Expense | 3.35M | 3.92M | 8.18M | 2.29M | 743.00K | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 21.84M | - | 69.69M | 45.27M | 54.02M | 106.68M |
| Current Assets | - | - | - | 44.89M | 24.01M | 34.69M | 47.55M |
| Cash & Equivalents | - | - | - | 10.46M | 434.00K | 31.17M | 32.22M |
| Inventory | - | - | - | 5.89M | 4.98M | 500.00K | 4.04M |
| Receivables | - | - | - | 1.07M | 855.00K | 30.00K | 9.32M |
| Total Liabilities | - | 28.29M | - | 78.73M | 59.98M | 25.93M | 93.66M |
| Current Liabilities | - | 27.03M | - | 70.60M | 41.25M | 24.68M | 42.96M |
| Long Term Debt | - | 829.00K | - | 407.00K | 16.05M | 1.00K | 50.00M |
| Total Debt | - | - | - | 31.71M | 21.80M | 10.52M | 80.62M |
| Total Equity | -805.00K | -6.68M | - | -9.27M | -14.94M | 28.09M | 13.02M |
| Shares Outstanding | - | - | - | 69.22K | 113.42K | 1.95M | 2.15M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.78M | - | -72.02M | -30.98M | -11.58M | -23.54M |
| Investing Cash Flow | -1.23M | - | -2.32M | 25.18M | -54.00K | -55.08M |
| Financing Cash Flow | 23.91M | - | 72.78M | -4.23M | 42.37M | 79.66M |
| Capital Expenditure | -136.00K | -2.32M | -8.13M | -59.00K | -4.00K | - |
| Free Cash Flow | -14.92M | - | -80.16M | -31.03M | -11.59M | -23.54M |
| Net Change in Cash | - | - | -1.56M | -10.02M | 30.74M | 1.05M |
| Dividends Paid | 583.00K | 61.00K | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | 4.7% | - | -54.6% | 26.5% | -394.4% | 59.0% |
| Operating Margin % | -104.4% | - | -210.6% | -94.7% | -40,294.4% | -138.1% |
| Net Margin % | -178.8% | - | -323.0% | -123.2% | -231,922.2% | -192.4% |
| ROE % | 323.7% | - | 2,029.5% | 124.8% | -148.6% | -255.4% |
| ROCE % | 243.1% | - | 13,406.1% | -356.5% | -24.7% | -37.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RYM
RYTHM, Inc. Reports Record Second-Quarter 2026 Revenue Growth and Strong THC Beverage Momentum - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQNGp5T3UtZnB1S1RDY2lIT3lDVXlXUV9nN05NYjQyd2ctRkZQQTZadkNLVXl5aWN5cGdNUnRGVGNmbWdvLVFma2VJOU1RZ3hrb2xVRlRORWNFNWVoTjB1b2wtNmJDNGg1ZlU4T3BqV283UTJMMUQtc1JYcG1CdHNGVDRtaGM2SS1yUDFiYW…
RYTHM, Inc. Revenue Breakdown – NASDAQ:RYM - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE42MVFibFNVTGktbEpxQzBqOWpMY3cydGFVdmxqbElERWloMUxQUE5WM1FlaGNGRDd6d2Y1T3VrM0VJUWNoWFZOVURlNXBVdmJpNDdRTldqWURJdnpuSy1yYzRPVzZiWFBxTVhwOTRZbFdONEVMdmc?oc=5" target="_blank">RYTHM, I…
Ryman Healthcare (ASX: RYM) Share Price Falls Today – Here’s What Happening - Kalkine
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNZ2l1RUNMdlQxeTB1SU1iR0tKamZ6cl80TlI0c3BjVklzTk9FQXRLN3I2M2RsYjR6WjdZUnloUVkzOFAxbGVjMk9xbTNTS01nejk3VHl6QU1mLVU1WGczVkdEblFCZ0FoeHhBdXJoTXlHdkR2R2NiUnpsdUV6Nkdmb0t5RXZ6Q1phYkkydU…
RYTHM stock surges 23% on amended Green Thumb license deal - Investing.com
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPYks4Q3d0WHdQUHotMm1DX1RqaFhKTURoNk96WFhlbWhqZ2RZRlduYzNoT25pcnBZcTRFbC0wRTN5WDlWalU0N0Y4S1ljb0dWY1N2cHp4RWFaM3hiSXRJc09Lc3lVOERZcGtRWGNMUXpZd2VVUzdoVXNfTVJmM3UxNzd0cFRybHpYbmhmQn…
RYTHM, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxOUmZfTjcwYU9fRWtDSHp2b1lleTg2TnEyenF5T3hUbnJPbWphLV9RWmc5Yy1vWmc5TmI3SkF0aF9UeHJrRm5oVmxNMXZuLXZmRXdWTi1GNHN2ejlaSVlRX01nU3dlSzFGZkdxXzJlTmdmWmdCVW9uSm9HaVRKcUxURktWWDRUXzFRRW5oaz…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5Zckt1b1RKNjdNRmRhdU9ManUwOWk5WXZQdmtzZmVzUWZFQk1QUVIzNkVVN3lSOXpHNkQtWFpKaEZhXy01VGt3OEUxSXdyeUU?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <font…
RYM — Frequently Asked Questions
What is the current share price of RYM?
As of 2026-08-05 17:25 PDT, RYM trades at $24.99 on NASDAQ/NYSE. Its 52-week range is $14.93 to $48.25.
What is the market capitalisation of RYM?
RYM has a market capitalisation of $53.71M on NASDAQ/NYSE.
What is the P/E ratio of RYM?
RYM trades at a trailing price-to-earnings (P/E) ratio of -1.50. Its price-to-book (P/B) ratio is 4.12.
Is RYM a good stock to buy?
This page provides a data-driven analysis of RYM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.